Prescription Drug Diversion and Counterfeiting: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, First-[second] Session, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1986 - Drug control
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
action Administration adulterated advised agency American appears asked Atkins attorney authority believe Board California cause Chairman Code Cole committee concern consumers container copies correct counterfeit court Customs dangerous deal December defendants Department Dingell distribution District diverted documents Eckert enforcement entries Exchange fact Federal firm Florida Food and Drug Fricano going Grant hearing hospitals importer investigation involved Katz Klepach labeling Lederle licensed manufacturers MARCHAR matter Medical Miami Military misbranded month obtained Ohio operation Orlando particular person pharmaceuticals pharmacists Pharmacy Pipracil prescription present problem purchase question received records regarding request retail returned Rinc samples Sandler Services shipment shipped Sims sold subcommittee Thank tion United violation warrant wholesale York Young